These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17897336)

  • 1. Targeting IL-6 in cholangiocarcinoma therapy.
    Mott JL; Gores GJ
    Am J Gastroenterol; 2007 Oct; 102(10):2171-2. PubMed ID: 17897336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of interleukin-6 (IL-6) for primary bile duct cancer and changes in serum IL-6 levels following photodynamic therapy.
    Cheon YK; Cho YD; Moon JH; Jang JY; Kim YS; Kim YS; Lee MS; Lee JS; Shim CS
    Am J Gastroenterol; 2007 Oct; 102(10):2164-70. PubMed ID: 17617204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An interleukin-6 (IL-6) receptor polymorphism affecting serum levels of IL-6 does not increase the risk of cholangiocarcinoma in primary sclerosing cholangitis.
    Melum E; Karlsen TH; Bergquist A; Schrumpf E; Boberg KM
    Am J Gastroenterol; 2008 Apr; 103(4):1045; author reply 1045-6. PubMed ID: 18397431
    [No Abstract]   [Full Text] [Related]  

  • 4. Endoscopic retrograde cholangiopancreatography in the diagnosis and management of cholangiocarcinoma.
    Coelho-Prabhu N; Baron TH
    Clin Liver Dis; 2010 May; 14(2):333-48. PubMed ID: 20682239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual cause of itching in a pregnancy (cholangiocarcinoma).
    Sadoon S; Hodgett S
    J Obstet Gynaecol; 2008 Feb; 28(2):230-1. PubMed ID: 18393029
    [No Abstract]   [Full Text] [Related]  

  • 7. Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma.
    Fujimoto K; Kawaguchi T; Nakashima O; Ono J; Ohta S; Kawaguchi A; Tonan T; Ohshima K; Yano H; Hayabuchi N; Izuhara K; Sata M
    Oncol Rep; 2011 May; 25(5):1211-6. PubMed ID: 21347516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy for cholangiocarcinoma: overview and new developments.
    Ortner MA
    Curr Opin Gastroenterol; 2009 Sep; 25(5):472-6. PubMed ID: 19550314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostics and treatment of cholangiocarcinoma].
    Mantel HT; Verdonk RC; van Dullemen HM; Gietema JA; Slooff MJ; Porte RJ
    Ned Tijdschr Geneeskd; 2008 May; 152(18):1037-41. PubMed ID: 18547024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures.
    Lempinen M; Isoniemi H; Mäkisalo H; Nordin A; Halme L; Arola J; Höckerstedt K; Stenman UH
    J Hepatol; 2007 Nov; 47(5):677-83. PubMed ID: 17640760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholangiocarcinoma.
    Patel T
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jan; 3(1):33-42. PubMed ID: 16397610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the clinical diagnosis and therapy of cholangiocarcinoma.
    Yao D; Kunam VK; Li X
    J Int Med Res; 2014 Feb; 42(1):3-16. PubMed ID: 24366497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achievable outcomes in the management of proximal cholangiocarcinoma: an update prepared using "evidence-based practice" techniques.
    Killeen RP; Harte S; Maguire D; Malone DE
    Abdom Imaging; 2008; 33(1):54-7. PubMed ID: 17874306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic management of cholangiocarcinoma.
    Abu-Hamda EM; Baron TH
    Semin Liver Dis; 2004 May; 24(2):165-75. PubMed ID: 15192789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
    Kahaleh M; Mishra R; Shami VM; Northup PG; Berg CL; Bashlor P; Jones P; Ellen K; Weiss GR; Brenin CM; Kurth BE; Rich TA; Adams RB; Yeaton P
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma.
    Tolek A; Wongkham C; Proungvitaya S; Silsirivanit A; Roytrakul S; Khuntikeo N; Wongkham S
    Exp Biol Med (Maywood); 2012 Oct; 237(10):1142-9. PubMed ID: 23104505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic role of serum interleukin 6 and CA 19-9 in patients with cholangiocarcinoma.
    Tangkijvanich P; Thong-ngam D; Theamboonlers A; Hanvivatvong O; Kullavanijaya P; Poovorawan Y
    Hepatogastroenterology; 2004; 51(55):15-9. PubMed ID: 15011822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholangiocarcinoma: an emerging indication for photodynamic therapy.
    Allison RR; Zervos E; Sibata CH
    Photodiagnosis Photodyn Ther; 2009 Jun; 6(2):84-92. PubMed ID: 19683207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel serum carbohydrate marker on mucin 5AC: values for diagnostic and prognostic indicators for cholangiocarcinoma.
    Silsirivanit A; Araki N; Wongkham C; Pairojkul C; Narimatsu Y; Kuwahara K; Narimatsu H; Wongkham S; Sakaguchi N
    Cancer; 2011 Aug; 117(15):3393-403. PubMed ID: 21287531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy: standard of care for palliation of cholangiocarcinoma?
    Baron TH
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):266-7. PubMed ID: 18328433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.